Sector Signals on Capital, Talent, and Regulation
Sector-deep perspectives on where industries are bending, breaking, and being rebuilt. Early indicators on shifts in business models, consumer behaviour, and operating economics.
Where healthcare capital is going in 2026, and what makes a single-specialty niche investable
In 2026, acquirers worldwide paid most for supplement brands, while venture funds put more into blood tests and wearables than into supplements. In India the money is moving into orthotics, pain care and physiotherapy. What turns a niche into a business an investor can price.
How the fabless model changed the semiconductor industry
Fabless chip companies design and sell chips but pay a foundry to make them. Why the split happened, how the model earns, where its risk sits, and what it means for Indian chip-design startups.
Why do so few farmers use India's custom hiring centres?
India has paid for tens of thousands of custom hiring centres, yet in Punjab only 15% of farmers who manage straw rent from them. Six reasons, from missing tractors to idle seeders.
Farm mechanisation in India has left its small farms behind
Nearly half of India's farm work is done by machine, though little of it on the smallest farms. Where machine power sits, why a one-hectare farm cannot own a tractor, and what reaches it instead.
Why tractor sales in Punjab hold up in a state that is already mechanised
Punjab's tractor fleet is three times as dense as India's, yet the state still buys thousands a year. Most purchases replace or upsize an old tractor, pushed by residue rules, subsidies and credit.
Why India imports the farm equipment it should be making
Trade data show where India's farm machinery imports really sit: harvesters, mostly Chinese. Why Indian makers have not won that business, and where one could start.
Where India's food processing industry makes its money, and where it loses it
India loses about ₹1.53 lakh crore of food a year between the farm and the factory, while most of the profit is made several stages later. What that gap means for processors and investors.
What stops a ₹100 crore food processing business reaching ₹500 crore
Many regional food processors stall around ₹100 crore on commodity margins, one category and one channel. Three moves can change the trajectory, if they come in the right order and on real numbers.
The handloom industry in India runs on credit, stock and records
Marketplaces have made handloom easier to find. They have not fixed who finances the yarn, who carries the stock, or who can prove where a saree came from, and that is where the value leaks.
Why a GI tag alone does not set the price of a saree
India has 103 handloom products registered under the GI Act, and most of them still sell next to copies using the same name. The tag is a starting right. Pricing power comes from what a business builds on it.
The SME IPO route in India, seen from the founder's side of the table
SEBI's 2025 rules made the SME IPO harder to use as a quick exit and better as a way for profitable small companies to raise growth capital. Here is how the route works, what it costs, and who should take it.
What a blockchain can and cannot prove about handloom provenance
Blockchain traceability is arriving in Indian handloom through EU-funded projects and state hubs. The ledger is the easy part. The record at the loom decides whether any of it is worth paying for.
MES, ERP, QMS and IoT: What Root Cause Analysis Needs to Connect To
A root cause investigation is only as good as the records it can read. What each plant system contributes, which ones most Indian plants actually have, and the order to connect them without starting a two-year IT project.
Why Indian Manufacturers Still Do Root Cause Analysis on Paper
Most Indian plants run root cause analysis in registers, WhatsApp threads and one senior technician's memory. The reasons are more interesting than cost, and the moment to switch is usually set by a customer or a regulator.
What Downtime Really Costs an Indian Plant, and What to Measure First
Global downtime benchmarks, converted to rupees, produce numbers larger than most Indian plants' revenue. Here is how to calculate the real cost for your own lines, and which five numbers any analytics effort should produce first.
How Big Is the Root Cause Analysis Software Market, Really?
Published estimates for root cause analysis software disagree more than threefold, and the most quoted one cannot be traced. Here is what the defensible numbers say, and where the value in the category is actually priced.
Micron Sanand and the Gujarat Chip Cluster: What Is Running and What Is Not
Gujarat hosts half of India's approved chip units and all three that are shipping. A plant-by-plant status check on Micron Sanand and its neighbours, and what it means for suppliers.
Urban Mining in India: Where the Gold in E-Waste Really Is
India imports almost all its gold while about 2 million tonnes of electronics are thrown away each year. Urban mining is real, but the money for small firms is in collection and sorting, not in refining.
HBM Memory, Advanced Packaging and the Real Limits on AI Chips
The binding limits on AI hardware sit in memory stacks, packaging lines and one Dutch toolmaker. How each chokepoint works, how fast it is easing, and who gets paid while it lasts.
Denial Management and the RCM Value Chain: Where Revenue Is Lost and Who Earns the Margin
Most claim denials are caused upstream and paid for downstream. How denial management actually works, how it differs for Indian hospitals, and why the most valuable position in the chain is the data it produces.
When a Medical Billing Outsourcing Company Stops Compounding, and What to Do About It
A mid-size Indian RCM company built on coding and billing seats will keep growing for a while and then stop compounding. The moves that change the trajectory, and the checks a hospital should run before outsourcing.
AR Days, Clean Claim Rate and the Other RCM Numbers a Hospital CFO Should Track
Most Indian hospitals know their revenue and their bed occupancy to the decimal, and their AR days only roughly. Here are the seven revenue cycle numbers worth tracking, with formulas and rupee examples.
Five Myths About Healthcare RCM and Medical Coding in India
Most of what founders, investors and hospital managers believe about medical coding and RCM in India is a decade out of date. Here are five beliefs that cost real money.
RCM Companies in India: Who Bought Them, Why, and What Buyers Look For
Between September 2024 and August 2026, nearly every large Indian-origin RCM company was bought by global private equity or filed to list. What the deals were, what drove them, and what buyers test for.
Healthcare BPO in India: Why US Hospitals Run Their Revenue Cycles From Here
India is one of the largest delivery bases for US hospitals' billing, coding and denial work. The industry is large, owned increasingly by global private equity, and about to be re-priced by AI.
Why the Cheapest Cybersecurity Decision an Indian SME Can Make Is Also the Most Expensive
Cybersecurity is often viewed as a cost centre until the day it becomes a crisis. By then, the economics change dramatically. This article breaks down the financial reality of cyber incidents for Indian SMEs, from operational downtime and recovery expenses to regulatory exposure and customer trust, and explains why prevention remains the cheapest strategy available.
3,195 Attacks Per Week. And Most Indian Companies Are Still Running Antivirus From 2019.
The threat has industrialised. The defence has not. This is the gap that is costing Indian businesses thousands of crores every year.
Your SOC Has 10 Analysts. AI Is About to Make 7 of Them Redundant. Here Is What the Other 3 Need to Become.
AI is automating alert triage, investigation and response, and the SOC analyst's job is being redesigned around it. What the remaining roles have to become, and which skills to build before the transition accelerates.
India Processes One-Third of the World's Security Alerts. Why Does It Still Import Its Security Thinking?
India runs a large share of the world's security operations, yet imports the intelligence and frameworks behind them. Why operational scale has not become intelligence ownership, and what that leaves open for Indian companies to build.
Why Modi Asked Indians to Stop Buying Gold
India spent a record $72 billion importing gold in FY26, and in May the Prime Minister asked households to hold off for a year. What he said, what the duty hike did, and why the lasting fix is getting existing gold to move.
Can AMTZ and Hyderabad's Medical Devices Park Make India a Medtech Maker?
India imports most of the medical devices its hospitals use. Two state-built clusters in Visakhapatnam and Hyderabad are trying to change that, with very different results so far.
From Checkups to Continuous Care: What Wearable Medical Devices Change
Medicine has run on snapshots: a ten-minute consultation, months apart. Wearable sensors replace the snapshot with a stream. The evidence is now strong in diabetes and heart rhythm, and the business model is a subscription.
Can Medical Equipment Think? What AI in Medical Devices Really Does
More than 1,200 AI-enabled devices are cleared in the US, most of them reading scans. The evidence is strong for narrow tasks and much weaker for the bigger claims. Here is how to tell the difference.
The Hidden Profit Engine of the Medical Equipment Industry
The scanner wins the tender. The cartridges, service contracts and software licences that follow it earn the money, often for a decade. Here is how recurring revenue works in medical equipment, and what it means in India.
Medical Tourism Could Be India's Most Underrated Dollar-Revenue Business
Foreign patients pay full price, often in advance and in hard currency, and they earn hospitals about 30% more per bed. India still treats medical tourism as a side business.
Why Most of India's New Hospital Beds Are Expansions, Not New Builds
India's hospital chains are adding tens of thousands of beds, and a large part of them are going into buildings that already exist. Here is why, what the real share is, and when a new build still makes sense.
Why Most Indian Hospitals Never Scale Past One Location
India has thousands of successful single hospitals and only a handful of chains. The traits that make the first hospital work are usually the ones that stop the second.
The Real Economics of Running a Hospital in India
A hospital is a capital project that happens to treat patients. Three numbers, capex per bed, revenue per occupied bed and occupancy, decide whether it ever pays back.
India's Semiconductor Opportunity: Can India Become a Global Chip Hub?
India now packages chips commercially and designs some of the world's most advanced ones. Whether it becomes a chip hub depends on the layers it does not yet own.
Why AI Is Creating the Biggest Semiconductor Boom in History
A handful of AI accelerators now earn about half the industry's revenue. Here is where that money lands along the semiconductor supply chain, and why the memory cycle is the part to watch.